Director/PDMR Shareholding

21 Dec 2007 15:54

Cyprotex PLC21 December 2007 Press Release 21 December 2007 Cyprotex PLC ("Cyprotex" or "the Company") Director share purchases Cyprotex PLC (AIM: CRX), the drug discovery technology and information companywas notified on 19 December 2007 that David Evans, a non-executive director ofthe Company purchased a total of 58,000 ordinary shares of 0.1p each in theCompany on 19 December 2007 at US$0.0741. David Evans now has a total interestof 83,000 ordinary shares in the Company, which represents 0.06% of the issuedshare capital of the Company. - Ends - For further information: Cyprotex PLCMark Warburton Tel: +44 (0) 1625 505100iir@cyprotex.com www.cyprotex.com This information is provided by RNS The company news service from the London Stock Exchange